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severe abdominal pain. 3 patients treated with glucose subsequently
underwent hysterosalpingography showing normal configuration
and patency of the affected tubes.
We feel the results of this study are promising and that treatment
with glucose could be a useful alternative to conventional methods.
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STEROID-INDUCED PSYCHOSIS
SIR,-Dr d’Orban (Sept 16, p 694) rightly draws attention to the
unsatisfactory state of the law with respect to steroid-induced
psychosis as a defence for criminal activity, but is not quite accurate
in stating that there is only one other publication on this matter. A
45-year-old man has been reported! who, following treatment with
prednisolone 30-60 mg daily for severe ulcerative colitis, was
convicted of shop lifting despite clear evidence of a steroid-induced
psychosis.
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SMOKING AND CEREBRAL ISCHAEMIA
S!R,&mdash;Dr Donnan and colleagues (Sept 16, p 643) show that
smokers have a much higher risk of stroke (relative risk 5-7) than
have non-smokers. After cessation of smoking the relative risk
declined but a significant risk was still evident ten years later.
MEAN LEVELS OF PLASMA FIBRINOGEN, PLASMA VISCOSITY, AND
WHITE CELL COUNT (WCC) IN MEN AGED 45-59 YEARS
I I I
In their interpretation of this last finding Donnan et al comment:
"the known effects of smoking on ... fibrinogen levels and blood
viscosity are reversible within a short period". They therefore
attribute the excess risk of cerebral ischaemia to atherogenesis rather
than to haemostatic processes. Their assumption that effects of
smoking on haemostasis are shortlived is, however, untrue. We have
evidence from two large cohorts of men in Caerphilly and in
Speedwe1l1 that effects of smoking on the haemostatic system are far
from shortlived and can be detected at least ten years after stopping
cigarettes (table). In fact, in relation to heart disease, our conclusion
is that the effect of smoking on heart disease may be mediated to a
large extent through the haemostatic system. Donnan and
colleagues’ evidence does not exclude this possibility in
cerebrovascular disease.
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RAISED PLASMA ALUMINIUM IN AN INFANT ON
ANTACID
SiR,&mdash;Correspondence in The Lancet (Dr Bishop and colleagues,
March 4, p 490, and Ms Lawson and colleagues, March 18 p 614)
has drawn attention to aluminium (Al) toxicity in infants. AI toxicity
has been looked for in users of Al-containing antacids. Although
such medications are used infrequently in young infants, ’Gaviscon’
(Reckitt and Colman) has been advocated for the management of
gastro-oesophageal reflux2 and we report the finding of strikingly
raised plasma Al concentration in a child treated in this way.
A male infant weighing 1 kg was delivered by emergency
caesarean section at 30 weeks’ gestation following antepartum
haemorrhage. He had 7 days’ ventilation for hyaline membrane
disease, during which time enteral feeding was established with
expressed breast milk, later changed to ’Premium’ (Cow and Gate).
At age 17 days he still needed an inspiratory oxygen concentration of
30% and he had recurrent apnoeas. Investigations, including septic
screen and electroencephalography, were normal; however, chest
radiographic changes were consistent with recurrent aspiration,
suggesting that the apnoeas might be related to gastro-oesophageal
reflux.3 Apnoeas became less frequent when the baby was nursed in
an anti-reflux posture and feeds were thickened with ’Carobel’
(Cow and Gate). When constipation and abdominal distension
occurred, ’Infant Gaviscon’ was substituted for carobel, one sachet
being added to 12 hours’ feed requirement. Each sachet contains
about 40 mg elemental Al as hydroxide, giving our patient about 53
mg Al/kg per day. Plasma analysis of venous blood after a week of
treatment showed an Al concentration of 43 ug/1 (upper reference
range 14 ug/1), plasma creatinine was within the normal range
1 week after stopping gaviscon, plasma AI was virtually unchanged
(42 gg/1), falling to 30 pg/1 and then 11 (ig/1 over the next 2 weeks.
We speculate that the high plasma Al in our patient was related to
absorption of Al from infant gaviscon, perhaps facilitated by the
higher content of citric acid in formula milk than in breast milk.’
Despite the fact that infant gaviscon is not recommended for use in
young infants because of its high sodium content we believe that it is
commonly used to treat symptoms suggestive of gastro-oesophageal
reflux. In view of the possible adverse results of excess AI absorption
we suggest that such treatment should be avoided in premature
babies or during early infancy.
We thank the Regional Toxicology Laboratory, Dudley Road Hospital, for
measurement of plasma aluminium.
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SPONTANEOUS LYMPHOCYTE PROLIFERATION IN
SYMPTOM-FREE HTLV-I POSITIVE JAMAICANS
SIR,&mdash;Jacobson et all report increased spontaneous proliferation
of lymphocytes in patients with HTLV-1-associated myelopathy/
tropical spastic paraperesis (HAM/TSP) who were infected with
human T-cell leukaemia virus (HTLV-1), but did not address the
issue of whether this was associated with disease (HAM/TSP) or
exposure (HTLV-I). We have looked at spontaneous lymphocyte
proliferation in HTLV-1-infected but symptom-free individuals to
see if other factors (eg, demographic and socioeconomic) influence
spontaneous proliferation.
Whole blood was obtained from Jamaicans taking part in
epidemiological studies of HTLV-I sponsored by the US National
Cancer Institute in collaboration with the University of the West
Indies and the Jamaican Ministry of Health-these studies had
been approved by review committees at both institutions and
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SPONTANEOUS LYMPHOCYTE PROLIFERATION RATES IN FOUR
GROUPS
participants gave informed consent-and from blood donors at the
National Institutes of Health blood bank whose blood was
designated for research purposes. The four groups (table) were:
Group l.-Healthy Jamaican HTLV-I seronegative, n =15.
Randomly chosen from a nationwide survey of HTLV-1 antibody
in 1985-86. Enrolled when seeking employment licences for
food-handling. Questionnaire and physical examination were
administered by trained personnel.
Group 2.-Healthy Jamaican HTLV-I seropositive, n=15.
From the same survey but testing positive for HTLV-I.
Group 3.-Patients with adult T-cell leukaemia/lymphoma
(ATL), n = 12. Enrolled in case-control study of haematological
malignancies.2 All had diffuse lymphoma, T-lymphocyte
phenotype of malignant cells, and antibodies to HTLV-I. Skin
infiltration and hypercalcaemia were common findings.
Group 4.-Healthy USA control, n = 13. Healthy blood donors
all seronegative for HTLV-I (and HIV-1).
Sera were tested for antibody to HTLV-I with a research ELISA
based on disrupted whole virus particles (Dupont). Positive samples
were confirmed by western blot (Biotech). Minimum criteria for a
positive western blot were bands specific to HTLV-1 gag proteins
p19 and p24.3 An env ELISA (Cambridge Bioscience) was also
done-ie, antibodies to two HTLV-1 gene groups were required for
a positive sample.
Cryopreserved lymphocytes were plated in triplicate at a
concentration of 3 x 105 per well in 96-well plates. We used RPMI
medium supplemented in 2% human AB serum. After 4, 5, and 6
days, wells were pulsed with 1 (iCi of 3H-thymidine for 4 h,
harvested (Skatron, Sterling, Virginia), and counted. Spontaneous
lymphoproliferation counts were log-transformed and analysed by
Student’s t-test. To evaluate risk factors odds ratios (OR) and 95%
confidence intervals (CI) were calculated for demographic and
lifestyle factors. Logistic regression was done to determine the
separate effects of HTLV-I serostatus and income. For these
purposes, variables were dichotomised at their median.
Spontaneous lymphocyte proliferation rates at day 6 are
summarised in the table. The important significant differences were
between seropositive and seronegative healthy Jamaicans,
seropositive healthy Jamaicans and seropositive patients with ATL,
and seronegative Jamaicans and US controls. There were no
correlations between proliferation rate and white blood cell or
lymphocyte counts.
Among the 30 healthy Jamaicans, the only demographic feature
(age, sex, socioeconomic status) associated with high
lymphoproliferation was low income. However, logistic regression
analysis revealed that HTLV-I seropositivity was a stronger risk
factor for high lymphoproliferation (OR =17 2, 95 % CI 1 8-164-7)
than was low income (OR = 8-5,95% CI 0-9-81-6).
Besides ATL and HAM/TSP, HTLV-1 infection has been
associated with immunodeficiency and in-vitro immunological
effects,’ including pertubations in T-cell subsets.1.s.6
Our data suggest that increased spontaneous lymphoproliferation
is associated with HTLV-I exposure per se. Since the rate of
proliferation was indistinguishable in HTLV-1 positives and
HAM/TSP patients,’ a mechanism that may yield insight into the
pathogenesis of HAM/TSP is provided by Sonoda and colleagues 6
They added HTLV-I antigens to lymphocytes and measured the
proliferation induced. HAM/TSP patients had a high proliferative
response while ATL patients were low responders. Family
members who shared certain HLA-haplotypes with HAM/TSP or
ATL patients showed high and low lymphocyte proliferation
responses, respectively. Perhaps virus infection in our study
resulted in viral antigen expression in vitro which stimulated
cells to spontaneous proliferation. The low spontaneous
lymphocyte proliferation in ATL probably reflects an
overabundance of HTLV-I-positive tumour cells that have lost
their capacity to proliferate. Individuals co-infected with HTLV-I
and HIV-1 may progress to AIDS at an accelerated rate.,,-10
HTLV-I lymphocyte proliferation may explain this.
HTLV-1-negative black Jamaicans had significantly higher
lymphoproliferation than US white controls. The reason for this
finding is unclear. Genetic factors may account for this difference."
However, it is also possible that spontaneous proliferation is
influenced by exposure to antigens and pathogens; and multiple
infections are more common in Jamaica than in the United States.
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EFFECT OF APROTININ ON INTRAOPERATIVE
BLEEDING AND FIBRINOLYSIS IN LIVER
TRANSPLANTATION
SIR,-Aprotinin has been reported to reduce blood loss in open
heart surgery1 and an increase in tissue plasminogen activator (tPA)
activity and a reduction of PA-inhibitor (PAI) have been said to be
responsible for fibrinolysis and sometimes uncontrollable bleeding
after reperfusion of the graft.2 Between September, 1988, and,
April, 1989, 20 orthotopic liver transplants were done in our clinic,
10 without (group 1) and 10 with (group II) intraoperative
prophylactic administration of 2-0 million IU aprotinin (’Trasylol’).
Blood loss after reperfusion of the graft was significantly higher in
patients not given aprotinin; in the longer duration of the procedure,
larger volumes of abdominal fluid drained, and the necessity for 2
re-laparotomies in group I (table) might have been a reflection of the
tendency towards sometimes severe fibrinolysis and bleeding in this
group.
We now give aprotinin routinely and in 40 liver transplants done
so far, no coagulation problems have been observed. Usually the
